Description
UCI-1 (University of California, Irvine Coronavirus Inhibitor-1) is a first-in-class cyclic peptide that inhibits SARS-CoV main protease (Mpro, also known as 3CLpro). UCI-1 was developed by Professor James S. Nowick and designed to mimic the autolytic cleavage site of SARS-CoV Mpro.
SEQUENCE: cyclo(-Phe-Gln-Ser-Lys-AEPA)
ONE-LETTER SEQUENCE: cyclo(-FQSK-AEPA)
MOLECULAR FORMULA: C33H45N7O7
MOLECULAR WEIGHT: 651.77
STORAGE CONDITIONS: -20 ± 5 °C
CAS REGISTRY NUMBER:
SYNONYMS:
RESEARCH AREA: COVID-19 Related Peptides
REFERENCES:
Kreutzer, Adam G., Maj Krumberger, Chelsea Marie T. Parrocha, Michael A. Morris, Gretchen Guaglianone, and James S. Nowick. BioRxiv (2020).
SKU(s): COVD-009
KEYWORDS: lactam

